BEACOPP-14 VS BEACOPP-ESC IN PATIENTS WITH HODGKIN'S LYMPHOMA FROM POOR-PROGNOSIS GROUP: PRELIMINARY RESULTS OF PROSPECTIVE RANDOMIZED MULTYCENTER STUDY

被引：0
|
作者：
Kriachok, I. [1 ]
Titorenko, I. [1 ]
Filonenko, K. [1 ]
Aleksik, E. [1 ]
Novosad, O. [1 ]
Kadnikova, T. [1 ]
Kushchevoy, E. [1 ]
Martinchik, A. [1 ]
Pastushenko, Y. [1 ]
机构：
[1] Natl Canc Inst, Kiev, Ukraine
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1366
引用
收藏
页码：550 / 550
页数：1
相关论文
共 50 条
  • [1] BEACOPP-14 Vs. BEACOPP-esc in Patients With Hodgkin's Disease From Poor-prognosis Group - Updated Results of Prospective Randomized Multicenter Study
    Titorenko, I.
    Kriachok, I.
    Filonenko, K.
    Novosad, O.
    Alexik, O.
    Kadnikova, T.
    Martynchik, A.
    Kadnikova, T.
    Kuscshevyy, E.
    Pastushenko, Y.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S648 - S648
  • [2] BEACOPP-14 VS BEACOPP-ESC IN PATIENTS WITH HODGKIN'S DISEASE FROM POOR-PROGNOSIS GROUP: INTERIM ANALISYS OF PROSPECTIVE RANDOMIZED MULTICENTER STUDY
    Kriachok, I.
    Titorenko, I.
    Filonenko, K.
    Aleksyk, E.
    Novosad, O.
    Oliynik, V.
    Stratiyenko, V.
    Kovtun, V.
    HAEMATOLOGICA, 2012, 97 : 89 - 89
  • [3] Pegfilgrastim support for full delivery of BEACOPP-14 chemotherapy for patients with high-risk Hodgkin's lymphoma: results of a phase II study
    Engert, Andreas
    Bredenfeld, Henning
    Doehner, Hartmut
    Ho, Anthony D.
    Schmitz, Norbert
    Berger, Dietmar
    Bacon, Pamela
    Skacel, Tomas
    Easton, Valerie
    Diehl, Volker
    HAEMATOLOGICA, 2006, 91 (04) : 546 - 549
  • [4] BEACOPP Chemotherapy Is Able to Induce Durable Complete Remission in Poor-Prognosis Hodgkin's Lymphoma Patients with a Positive Interim PET after 2 ABVD Cycles.
    Gallamini, Andrea
    Rambaldi, Alessandro
    Biggi, Alberto
    Tavera, Silvia
    Patti, Caterina
    Stelitano, Caterina
    Gianni, Alessandro M.
    Di Raimondo, Francesco
    Torchio, PierFederico
    Rossi, Andrea
    Mistretta, Alessandro
    Viviani, Simonetta
    Chiarenza, Alessandra
    Gavarotti, Paolo
    Tarella, Corrado
    BLOOD, 2008, 112 (11) : 899 - 899
  • [5] Promising results with a 14 day variant of the BEACOPP regimen in advanced stage Hodgkin's lymphoma (HL): A pilot-study of the German Hodgkin lymphoma study group (GHSG).
    Sieber, M
    Franklin, J
    Bredenfeld, H
    Naumann, R
    Boissevain, F
    Koch, P
    Heinz, H
    Worst, P
    Soekler, M
    Rueffer, U
    Paulus, U
    Josting, A
    Wolf, J
    Tesch, H
    Engert, A
    Diehl, V
    BLOOD, 2001, 98 (11) : 769A - 769A
  • [6] ABVD Versus Escalated Beacopp in Advanced Stage Hodgkin's Lymphoma: Results from a Retrospective, Multicenter European Study
    Mondello, Patrizia
    Dogliotti, Irene
    Bohn, Jan-Paul
    Cavallo, Federica
    Ferrero, Simone
    Botto, Barbara
    Cerchione, Claudio
    Nappi, Davide
    De Lorenzo, Sonya
    Martinelli, Giovanni
    Wolf, Dominik
    Loseto, Giacomo
    Cuzzocrea, Salvatore
    Willenbacher, Wolfgang
    Mian, Michael
    BLOOD, 2019, 134
  • [7] BEACOPP chemotherapy in elderly patients with advanced Hodgkin's disease: Analysis of the randomized trial HD9 for elderly patients of the German Hodgkin lymphoma study group (GHSG).
    Ballova, V
    Franklin, J
    Josting, A
    Wolf, J
    Diehl, V
    Engert, A
    BLOOD, 2003, 102 (11) : 400A - 400A
  • [8] Eight Cycles of BEACOPP Escalated Compared with 4 Cycles of BEACOPP Escalated followed by 4 Cycles of BEACOPP Baseline with or without Radiotherapy in Patients in Advanced-stage Hodgkin Lymphoma (HL): Final Analysis of the Randomized HD12 Trial of the German Hodgkin Study Group (GHSG)
    Eich, H.
    Engert, A.
    Haverkamp, H.
    Staar, S.
    Kriz, J.
    Engenhart-Cabillic, R.
    Lukas, P.
    Willich, N.
    Diehl, V.
    Mueller, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S3 - S4
  • [9] BEACOPP chemotherapy for advanced Hodgkin's disease (HD) is more effective with dose escalation:: German Hodgkin Lymphoma Study Group interim results.
    Diehl, V
    Wolf, J
    Franklin, J
    Engert, A
    Hasenclever, D
    Müller-Hermelink, HK
    Hermann, R
    Tesch, H
    Paulus, U
    Loeffler, M
    ANNALS OF ONCOLOGY, 2000, 11 : 99 - 100
  • [10] TARGETED BEACOPP VARIANTS IN PATIENTS WITH NEWLY DIAGNOSED ADVANCED STAGE CLASSICAL HODGKIN LYMPHOMA: INTERIM RESULTS OF A RANDOMIZED PHASE II STUDY
    Borchmann, P.
    Eichenauer, D.
    Pluetschow, A.
    Kreissl, S.
    Fuchs, M.
    Soekler, M.
    Engel, N.
    Mathas, S.
    Behringer, K.
    Kobe, C.
    Dietlein, M.
    Diehl, V.
    Engert, A.
    HAEMATOLOGICA, 2014, 99 : 497 - 498
12345